Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Tenet Healthcare (THC) and Cyclerion Therapeutics (CYCN).
Tenet Healthcare (THC)
In a report released yesterday, A.J. Rice from Credit Suisse maintained a Buy rating on Tenet Healthcare, with a price target of $27.00. The company’s shares closed last Tuesday at $25.37.
According to TipRanks.com, Rice is a 4-star analyst with an average return of 5.9% and a 58.1% success rate. Rice covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, Community Health, and Encompass Health.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tenet Healthcare with a $27.09 average price target.
See today’s analyst top recommended stocks >>
Cyclerion Therapeutics (CYCN)
In a report released yesterday, Martin Auster from Credit Suisse maintained a Hold rating on Cyclerion Therapeutics, with a price target of $5.00. The company’s shares closed last Tuesday at $4.00.
According to TipRanks.com, Auster is a 5-star analyst with an average return of 16.3% and a 57.8% success rate. Auster covers the Healthcare sector, focusing on stocks such as Entasis Therapeutics Holdings, Ultragenyx Pharmaceutical, and Alexion Pharmaceuticals.
The the analyst consensus on Cyclerion Therapeutics is currently a Hold rating.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
